Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications. Data Sources: PubMed was searched (to December 5, 2011 ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.